These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 9589354)

  • 41. Comparative polymerase chain reaction analysis of c-myc amplification on archival breast fine-needle aspiration materials.
    Rao JY; Apple SK; Jin Y; Lin S; Nieberg RK; Hirtschowitz SL
    Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):175-9. PubMed ID: 10698478
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quantitative measurement of epidermal growth factor receptor is a negative predictive factor for tamoxifen response in hormone receptor positive premenopausal breast cancer.
    Giltnane JM; Rydén L; Cregger M; Bendahl PO; Jirström K; Rimm DL
    J Clin Oncol; 2007 Jul; 25(21):3007-14. PubMed ID: 17634479
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prostate-specific antigen production in the female breast: association with progesterone.
    Sauter ER; Babb J; Daly M; Engstrom PF; Ehya H; Malick J; Diamandis E
    Cancer Epidemiol Biomarkers Prev; 1998 Apr; 7(4):315-20. PubMed ID: 9568787
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression of cytokeratin markers, ER-alpha, PR, HER-2/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the breast.
    Steinman S; Wang J; Bourne P; Yang Q; Tang P
    Ann Clin Lab Sci; 2007; 37(2):127-34. PubMed ID: 17522367
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinicopathologic analysis of breast lesions associated with multiple papillomas.
    Ali-Fehmi R; Carolin K; Wallis T; Visscher DW
    Hum Pathol; 2003 Mar; 34(3):234-9. PubMed ID: 12673557
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Patterns of reduced nipple aspirate fluid production and ductal lavage cellularity in women at high risk for breast cancer.
    Higgins SA; Matloff ET; Rimm DL; Dziura J; Haffty BG; King BL
    Breast Cancer Res; 2005; 7(6):R1017-22. PubMed ID: 16280052
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Correlations among p53, Her-2/neu, and ras overexpression and aneuploidy by multiparameter flow cytometry in human breast cancer: evidence for a common phenotypic evolutionary pattern in infiltrating ductal carcinomas.
    Smith CA; Pollice AA; Gu LP; Brown KA; Singh SG; Janocko LE; Johnson R; Julian T; Hyams D; Wolmark N; Sweeney L; Silverman JF; Shackney SE
    Clin Cancer Res; 2000 Jan; 6(1):112-26. PubMed ID: 10656439
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sex hormones, risk factors, and risk of estrogen receptor-positive breast cancer in older women: a long-term prospective study.
    Cummings SR; Lee JS; Lui LY; Stone K; Ljung BM; Cauleys JA
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1047-51. PubMed ID: 15894651
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material.
    Xu R; Perle MA; Inghirami G; Chan W; Delgado Y; Feiner H
    Mod Pathol; 2002 Feb; 15(2):116-24. PubMed ID: 11850540
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differences in the pathologic and molecular features of intraductal breast carcinoma between younger and older women.
    Rodrigues NA; Dillon D; Carter D; Parisot N; Haffty BG
    Cancer; 2003 Mar; 97(6):1393-403. PubMed ID: 12627502
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chemoprevention Indication Score: a user-friendly tool for prevention of breast cancer - pilot analysis.
    Layeequr Rahman R; Crawford S
    Breast; 2009 Oct; 18(5):289-93. PubMed ID: 19716702
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Retinoic acid receptor-beta2 promoter methylation in random periareolar fine needle aspiration.
    Bean GR; Scott V; Yee L; Ratliff-Daniel B; Troch MM; Seo P; Bowie ML; Marcom PK; Slade J; Kimler BF; Fabian CJ; Zalles CM; Broadwater G; Baker JC; Wilke LG; Seewaldt VL
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):790-8. PubMed ID: 15824145
    [TBL] [Abstract][Full Text] [Related]  

  • 53. p53 overexpression is a predictor of local recurrence after treatment for both in situ and invasive ductal carcinoma of the breast.
    de Roos MA; de Bock GH; de Vries J; van der Vegt B; Wesseling J
    J Surg Res; 2007 Jun; 140(1):109-14. PubMed ID: 17291532
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Stratification of breast cancer risk in women with atypia: a Mayo cohort study.
    Degnim AC; Visscher DW; Berman HK; Frost MH; Sellers TA; Vierkant RA; Maloney SD; Pankratz VS; de Groen PC; Lingle WL; Ghosh K; Penheiter L; Tlsty T; Melton LJ; Reynolds CA; Hartmann LC
    J Clin Oncol; 2007 Jul; 25(19):2671-7. PubMed ID: 17563394
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence of aneuploidy, overexpressed ER, and overexpressed EGFR in random breast aspirates of women at high and low risk for breast cancer.
    Fabian CJ; Zalles C; Kamel S; Kimler BF; McKittrick R; Tranin AS; Zeiger S; Moore WP; Hassanein RS; Simon C
    Breast Cancer Res Treat; 1994; 30(3):263-74. PubMed ID: 7981444
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pathology and heredity of breast cancer in younger women.
    Marcus JN; Watson P; Page DL; Lynch HT
    J Natl Cancer Inst Monogr; 1994; (16):23-34. PubMed ID: 7999466
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Papillary apocrine change of the breast: associations with atypical hyperplasia and risk of breast cancer.
    Page DL; Dupont WD; Jensen RA
    Cancer Epidemiol Biomarkers Prev; 1996 Jan; 5(1):29-32. PubMed ID: 8770463
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Nuclear DNA ploidy pattern and cytological atypia in aspiration cytology of breast cancer].
    Okazaki A; Okazaki M; Okazaki Y; Minamida H; Asaishi K; Hirata K
    Gan To Kagaku Ryoho; 1993 Apr; 20(6):812-5. PubMed ID: 8489291
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nuclear grading and flow cytometric DNA pattern in fine-needle aspirates of primary breast cancer.
    Bozzetti C; Nizzoli R; Naldi N; Guazzi A; Camisa R; Manotti L; Pilato FP; Mazzini G; Cocconi G
    Diagn Cytopathol; 1996 Aug; 15(2):116-20. PubMed ID: 8872432
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Women at high risk for breast cancer: can we define a group of women in France who could participate in a prevention trial?].
    Lê MG; Plu-Bureau G
    Contracept Fertil Sex; 1995 Mar; 23(3):199-202. PubMed ID: 7728186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.